HKD 11.24
(1.81%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 142.86 Million CNY | 54.87% |
2022 | 92.24 Million CNY | 4.44% |
2021 | 88.32 Million CNY | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 11.49 Million CNY | -61.96% |
2024 Q1 | 30.2 Million CNY | -78.86% |
2023 Q4 | 142.86 Million CNY | 119.13% |
2023 FY | 142.86 Million CNY | 54.87% |
2023 Q3 | 65.19 Million CNY | 0.0% |
2023 Q1 | - CNY | -100.0% |
2022 Q4 | 92.24 Million CNY | 0.0% |
2022 FY | 92.24 Million CNY | 4.44% |
2021 FY | 88.32 Million CNY | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Uni-Bio Science Group Limited | -76.36 Million HKD | 287.072% |
CK Life Sciences Int'l., (Holdings) Inc. | 5.26 Billion HKD | 97.287% |